Jinyu Bio-technology Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Jinyu Bio-technology Co., Ltd. carries a market capitalization of 14.16B, placing it among publicly traded companies globally. Its enterprise value stands at 7.78B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 14.16B |
| Enterprise Value | 7.78B |
Share Statistics
Jinyu Bio-technology Co., Ltd. currently has 1.12B shares outstanding.
| Shares Outstanding | 1.12B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Jinyu Bio-technology Co., Ltd. trades at a trailing price-to-earnings ratio of 188.48. The price-to-sales ratio is 6.94, and the price-to-book ratio stands at 2.02.
| PE Ratio | 188.48 |
| PS Ratio | 6.94 |
| PB Ratio | 2.02 |
| P/TBV Ratio | 1.81 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Jinyu Bio-technology Co., Ltd. trades at an EV/EBITDA multiple of 136.66 and an EV/FCF ratio of 100.90. The EV/Sales ratio of 6.16 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 136.66 provides insight into valuation relative to core operating earnings.
| EV / Sales | 6.16 |
| EV / EBITDA | 136.66 |
| EV / EBIT | 136.66 |
| EV / FCF | 100.90 |
Financial Position
Jinyu Bio-technology Co., Ltd. maintains a current ratio of 2.79, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.31, indicating conservative leverage, while an interest coverage ratio of 34.41 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.79 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 0.30 |
| Interest Coverage | 34.41 |
Financial Efficiency
Jinyu Bio-technology Co., Ltd. posts a return on equity of 1.07 and a return on invested capital of 0.78.
| Return on Equity (ROE) | 1.07 |
| Return on Assets (ROA) | 0.69 |
| Return on Invested Capital (ROIC) | 0.78 |
| Return on Capital Employed (ROCE) | 1.24 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.05 |
Taxes
Over the trailing twelve months, Jinyu Bio-technology Co., Ltd. has paid 12.78M in income taxes, reflecting an effective tax rate of 24.58.
| Income Tax | 12.78M |
| Effective Tax Rate | 24.58 |
Stock Price Statistics
Jinyu Bio-technology Co., Ltd.'s stock has gained approximately 59.44931% over the past 52 weeks. The 50-day moving average sits at 12.95, while the 200-day moving average is 13.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | 59.44931% |
| 50-Day Moving Average | 12.95 |
| 200-Day Moving Average | 13.73 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached 56.94M, while operating income came in at 56.94M.
| Revenue | 1.26B |
| Gross Profit | 645.49M |
| Operating Income | 56.94M |
| Pretax Income | 52.00M |
| Net Income | 46.49M |
| EBITDA | 56.94M |
| EBIT | 56.94M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
Jinyu Bio-technology Co., Ltd. holds 1.10B in cash and equivalents against 17.18M in total debt, resulting in a net debt position of -1.04B. Total book value stands at 4.35B, with working capital of 1.35B providing operational flexibility.
| Cash & Cash Equivalents | 1.10B |
| Total Debt | 17.18M |
| Net Debt | -1.04B |
| Equity (Book Value) | 4.35B |
| Book Value Per Share | 3.98 |
| Working Capital | 1.35B |
Cash Flow
After subtracting -75.87M in capital expenditures, free cash flow totaled -75.87M - equivalent to -0.07 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -75.87M |
| Free Cash Flow | -75.87M |
| FCF Per Share | -0.07 |
Margins
Jinyu Bio-technology Co., Ltd. operates with a gross margin of 51.10, reflecting its pricing power and cost economics. The operating margin of 4.51 and net profit margin of 3.68 provide insight into operational efficiency.
| Gross Margin | 51.10 |
| Operating Margin | 4.51 |
| Pretax Margin | 4.12 |
| Profit Margin | 3.68 |
| EBITDA Margin | 4.51 |
Dividends & Yields
The company's payout ratio of 104.23 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.03 |
| Dividend Yield | N/A |
| Payout Ratio | 104.23 |
| Shareholder Yield | 3.73 |
| FCF Yield | N/A |
Stock Splits
Jinyu Bio-technology Co., Ltd.'s most recent stock split took place on June 25, 2018 with a 10:13 split ratio.
| Last Split Date | 6/25/2018 |
| Split Ratio | 10:13 |
Scores
Jinyu Bio-technology Co., Ltd. posts an Altman Z-Score of 6.05, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.05 |